Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,293.40 -24.84 -0.16%
S&P 500 1,647.75 -4.06 -0.25%
Nasdaq 3,480.00 -2.18 -0.06%
Ticker Volume Price Price Delta
STOXX 50 2,686.89 -14.04 -0.52%
FTSE 100 6,337.38 -36.83 -0.58%
DAX 8,202.97 -26.54 -0.32%
Ticker Volume Price Price Delta
Nikkei 13,245.20 +237.94 1.83%
Hang Seng 20,986.90 -238.99 -1.13%
S&P/ASX 200 4,861.38 +47.03 0.98%
  • Exchange: Korea SE
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Yungjin Pharmaceutical Co Ltd

+ Add to Watchlist

003520:KS

1,710 KRW 35 2.01%

As of 02:24:27 ET on 06/19/2013.

Snapshot for Yungjin Pharmaceutical Co Ltd (003520)

Open: 1,750 Day's Range: 1,710 - 1,765 Volume: 1,007,136
Previous Close: 1,745 52wk Range: 1,445 - 2,780 1-Yr Rtn: +8.92%

Stock Chart for 003520

No chart data available.
  • 003520:KS 1,710
  • 1D
  • 1M
  • 1Y
1,745
Interactive 003520 Chart

Previous Close

Key Statistics for 003520

Current P/E Ratio (ttm) 171.0000
Estimated P/E(-) -
Relative P/E vs. KOSPI 6.7187
Earnings Per Share (ttm) 10.0000
Est. EPS -
Est. PEG Ratio -
Market Cap (M KRW) 303,730.19
Shares Outstanding (M) 177.62
30 Day Average Volume 2,349,246
Price/Book (mrq) 3.3352
Price/Sale (ttm) 2.2059
Dividend Indicated Gross Yield -%
Cash Dividend (KRW) -
Last Dividend 01/04/2000
5 Year Dividend Growth -
Next Earnings Announcement 07/18/2013
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 003520

  • Revenue
  • Net Income (M/KRW)
  • Profit Margin (%)

Company Profile & Key Executives for 003520

Yungjin Pharmaceutical Co., Ltd. manufactures pharmaceutical and medical drugs, such as nutritional drinks, antibiotics, and intravenous fluids.

Ryu Byeong-HwanPresident
More Company Profile & Key Executives for 003520

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Financial Commentaries

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil